IBDEI0Q5 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,11750,1,4,0)
;;=4^N04.5
;;^UTILITY(U,$J,358.3,11750,2)
;;=^5015536
;;^UTILITY(U,$J,358.3,11751,0)
;;=N04.6^^46^573^52
;;^UTILITY(U,$J,358.3,11751,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11751,1,3,0)
;;=3^Nephrotic syndrome w/ dense deposit disease
;;^UTILITY(U,$J,358.3,11751,1,4,0)
;;=4^N04.6
;;^UTILITY(U,$J,358.3,11751,2)
;;=^5015537
;;^UTILITY(U,$J,358.3,11752,0)
;;=N04.7^^46^573^53
;;^UTILITY(U,$J,358.3,11752,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11752,1,3,0)
;;=3^Nephrotic syndrome w/ diffuse crescentic glomerulonephritis
;;^UTILITY(U,$J,358.3,11752,1,4,0)
;;=4^N04.7
;;^UTILITY(U,$J,358.3,11752,2)
;;=^5015538
;;^UTILITY(U,$J,358.3,11753,0)
;;=N04.8^^46^573^60
;;^UTILITY(U,$J,358.3,11753,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11753,1,3,0)
;;=3^Nephrotic syndrome w/ other morphologic changes
;;^UTILITY(U,$J,358.3,11753,1,4,0)
;;=4^N04.8
;;^UTILITY(U,$J,358.3,11753,2)
;;=^5015539
;;^UTILITY(U,$J,358.3,11754,0)
;;=N04.9^^46^573^61
;;^UTILITY(U,$J,358.3,11754,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11754,1,3,0)
;;=3^Nephrotic syndrome w/ unspecified morphologic changes
;;^UTILITY(U,$J,358.3,11754,1,4,0)
;;=4^N04.9
;;^UTILITY(U,$J,358.3,11754,2)
;;=^5015540
;;^UTILITY(U,$J,358.3,11755,0)
;;=N05.0^^46^573^49
;;^UTILITY(U,$J,358.3,11755,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11755,1,3,0)
;;=3^Nephritic syndrome unspec w/ minor glomerular abnormality
;;^UTILITY(U,$J,358.3,11755,1,4,0)
;;=4^N05.0
;;^UTILITY(U,$J,358.3,11755,2)
;;=^5015541
;;^UTILITY(U,$J,358.3,11756,0)
;;=N05.1^^46^573^48
;;^UTILITY(U,$J,358.3,11756,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11756,1,3,0)
;;=3^Nephritic syndrome unspec w/ focal & segmental glomerular lesions
;;^UTILITY(U,$J,358.3,11756,1,4,0)
;;=4^N05.1
;;^UTILITY(U,$J,358.3,11756,2)
;;=^5015542
;;^UTILITY(U,$J,358.3,11757,0)
;;=N05.2^^46^573^45
;;^UTILITY(U,$J,358.3,11757,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11757,1,3,0)
;;=3^Nephritic syndrome unspec w/ diffuse membranous glomrlneph
;;^UTILITY(U,$J,358.3,11757,1,4,0)
;;=4^N05.2
;;^UTILITY(U,$J,358.3,11757,2)
;;=^5015543
;;^UTILITY(U,$J,358.3,11758,0)
;;=N05.3^^46^573^46
;;^UTILITY(U,$J,358.3,11758,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11758,1,3,0)
;;=3^Nephritic syndrome unspec w/ diffuse mesangial prolif glomrlneph
;;^UTILITY(U,$J,358.3,11758,1,4,0)
;;=4^N05.3
;;^UTILITY(U,$J,358.3,11758,2)
;;=^5015544
;;^UTILITY(U,$J,358.3,11759,0)
;;=N05.4^^46^573^44
;;^UTILITY(U,$J,358.3,11759,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11759,1,3,0)
;;=3^Nephritic syndrome unspec w/ diffuse endocaplry prolif glomrlneph
;;^UTILITY(U,$J,358.3,11759,1,4,0)
;;=4^N05.4
;;^UTILITY(U,$J,358.3,11759,2)
;;=^5015545
;;^UTILITY(U,$J,358.3,11760,0)
;;=N05.5^^46^573^47
;;^UTILITY(U,$J,358.3,11760,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11760,1,3,0)
;;=3^Nephritic syndrome unspec w/ diffuse mesangiocap glomrlneph
;;^UTILITY(U,$J,358.3,11760,1,4,0)
;;=4^N05.5
;;^UTILITY(U,$J,358.3,11760,2)
;;=^5015546
;;^UTILITY(U,$J,358.3,11761,0)
;;=N05.6^^46^573^42
;;^UTILITY(U,$J,358.3,11761,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11761,1,3,0)
;;=3^Nephritic syndrome unspec w/ dense deposit disease
;;^UTILITY(U,$J,358.3,11761,1,4,0)
;;=4^N05.6
;;^UTILITY(U,$J,358.3,11761,2)
;;=^5015547
;;^UTILITY(U,$J,358.3,11762,0)
;;=N05.7^^46^573^43
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0Q5 3789 printed Sep 23, 2025@19:29:35 Page 2
IBDEI0Q5 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,11750,1,4,0)
+2 ;;=4^N04.5
+3 ;;^UTILITY(U,$J,358.3,11750,2)
+4 ;;=^5015536
+5 ;;^UTILITY(U,$J,358.3,11751,0)
+6 ;;=N04.6^^46^573^52
+7 ;;^UTILITY(U,$J,358.3,11751,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,11751,1,3,0)
+10 ;;=3^Nephrotic syndrome w/ dense deposit disease
+11 ;;^UTILITY(U,$J,358.3,11751,1,4,0)
+12 ;;=4^N04.6
+13 ;;^UTILITY(U,$J,358.3,11751,2)
+14 ;;=^5015537
+15 ;;^UTILITY(U,$J,358.3,11752,0)
+16 ;;=N04.7^^46^573^53
+17 ;;^UTILITY(U,$J,358.3,11752,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,11752,1,3,0)
+20 ;;=3^Nephrotic syndrome w/ diffuse crescentic glomerulonephritis
+21 ;;^UTILITY(U,$J,358.3,11752,1,4,0)
+22 ;;=4^N04.7
+23 ;;^UTILITY(U,$J,358.3,11752,2)
+24 ;;=^5015538
+25 ;;^UTILITY(U,$J,358.3,11753,0)
+26 ;;=N04.8^^46^573^60
+27 ;;^UTILITY(U,$J,358.3,11753,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,11753,1,3,0)
+30 ;;=3^Nephrotic syndrome w/ other morphologic changes
+31 ;;^UTILITY(U,$J,358.3,11753,1,4,0)
+32 ;;=4^N04.8
+33 ;;^UTILITY(U,$J,358.3,11753,2)
+34 ;;=^5015539
+35 ;;^UTILITY(U,$J,358.3,11754,0)
+36 ;;=N04.9^^46^573^61
+37 ;;^UTILITY(U,$J,358.3,11754,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,11754,1,3,0)
+40 ;;=3^Nephrotic syndrome w/ unspecified morphologic changes
+41 ;;^UTILITY(U,$J,358.3,11754,1,4,0)
+42 ;;=4^N04.9
+43 ;;^UTILITY(U,$J,358.3,11754,2)
+44 ;;=^5015540
+45 ;;^UTILITY(U,$J,358.3,11755,0)
+46 ;;=N05.0^^46^573^49
+47 ;;^UTILITY(U,$J,358.3,11755,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,11755,1,3,0)
+50 ;;=3^Nephritic syndrome unspec w/ minor glomerular abnormality
+51 ;;^UTILITY(U,$J,358.3,11755,1,4,0)
+52 ;;=4^N05.0
+53 ;;^UTILITY(U,$J,358.3,11755,2)
+54 ;;=^5015541
+55 ;;^UTILITY(U,$J,358.3,11756,0)
+56 ;;=N05.1^^46^573^48
+57 ;;^UTILITY(U,$J,358.3,11756,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,11756,1,3,0)
+60 ;;=3^Nephritic syndrome unspec w/ focal & segmental glomerular lesions
+61 ;;^UTILITY(U,$J,358.3,11756,1,4,0)
+62 ;;=4^N05.1
+63 ;;^UTILITY(U,$J,358.3,11756,2)
+64 ;;=^5015542
+65 ;;^UTILITY(U,$J,358.3,11757,0)
+66 ;;=N05.2^^46^573^45
+67 ;;^UTILITY(U,$J,358.3,11757,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,11757,1,3,0)
+70 ;;=3^Nephritic syndrome unspec w/ diffuse membranous glomrlneph
+71 ;;^UTILITY(U,$J,358.3,11757,1,4,0)
+72 ;;=4^N05.2
+73 ;;^UTILITY(U,$J,358.3,11757,2)
+74 ;;=^5015543
+75 ;;^UTILITY(U,$J,358.3,11758,0)
+76 ;;=N05.3^^46^573^46
+77 ;;^UTILITY(U,$J,358.3,11758,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,11758,1,3,0)
+80 ;;=3^Nephritic syndrome unspec w/ diffuse mesangial prolif glomrlneph
+81 ;;^UTILITY(U,$J,358.3,11758,1,4,0)
+82 ;;=4^N05.3
+83 ;;^UTILITY(U,$J,358.3,11758,2)
+84 ;;=^5015544
+85 ;;^UTILITY(U,$J,358.3,11759,0)
+86 ;;=N05.4^^46^573^44
+87 ;;^UTILITY(U,$J,358.3,11759,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,11759,1,3,0)
+90 ;;=3^Nephritic syndrome unspec w/ diffuse endocaplry prolif glomrlneph
+91 ;;^UTILITY(U,$J,358.3,11759,1,4,0)
+92 ;;=4^N05.4
+93 ;;^UTILITY(U,$J,358.3,11759,2)
+94 ;;=^5015545
+95 ;;^UTILITY(U,$J,358.3,11760,0)
+96 ;;=N05.5^^46^573^47
+97 ;;^UTILITY(U,$J,358.3,11760,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,11760,1,3,0)
+100 ;;=3^Nephritic syndrome unspec w/ diffuse mesangiocap glomrlneph
+101 ;;^UTILITY(U,$J,358.3,11760,1,4,0)
+102 ;;=4^N05.5
+103 ;;^UTILITY(U,$J,358.3,11760,2)
+104 ;;=^5015546
+105 ;;^UTILITY(U,$J,358.3,11761,0)
+106 ;;=N05.6^^46^573^42
+107 ;;^UTILITY(U,$J,358.3,11761,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,11761,1,3,0)
+110 ;;=3^Nephritic syndrome unspec w/ dense deposit disease
+111 ;;^UTILITY(U,$J,358.3,11761,1,4,0)
+112 ;;=4^N05.6
+113 ;;^UTILITY(U,$J,358.3,11761,2)
+114 ;;=^5015547
+115 ;;^UTILITY(U,$J,358.3,11762,0)
+116 ;;=N05.7^^46^573^43
